IKBKB and diffuse large B-cell lymphoma: Oncogenic addiction of ABC DLBCL cells to high NF-κB activity has been demonstrated by the selective cytotoxicity of IKKβ inhibitors, providing a clear rational for therapeutic strategies targeting IKKβ/NF-κB [62,170].